As a leader within the field of research of hair

Nourkrin® is committed to ensuring its recognition as a benchmark for excellence – not only by consumers, but also by scientists, dermatologists, cosmetologists and aestheticians worldwide.

Nourkrin® is based on more than 56 scientific studies and clinical papers as well as several consumer studies published in leading peer-review journals.

Nourkrin® has been tested in placebo, double-blind studies and shown to be side effect free.* This is in contrast to other pharmaceuticals, which may cause; scalp itching, dryness, scaling, flaking, irritation, burning and in extreme instances weight gain, swelling of the face, ankles, hands or stomach, difficulty breathing (especially when lying down), rapid heartbeat, chest pain and light headedness.**

Nourkrin® continues to partner with the world’s leading authorities on hair loss and hair thinning based on its clinically documented efficacy and safety standards.

Nourkrin® contains naturally based ingredients that have been scientifically documented to be safe and effective.

*2006, 2012, 2014, 2016 and 2018 studies published in leading international clinical journals.
**Studies about finastride: Kaufman KD, Olsen EA, Whiting D, Savin R, DeVillez R, Bergfeld W, et al. Finastride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol .1998;39:578-89 & Leyden J, Dunlap F, Miller B, Winters P, Lebwohl M, Hecker D, et al. Finasteride in the treatment of men with frontal male pattern hair loss. J Am Acad Dermatol.1999;40;930-7.

Selected published clinical studies

'...a highly significant favour of the Nourkrin® treatment group'

2006 Clinical Study on the Nourkrin® effect and tolerability

Selected published clinical studies

'… utilizing a proteoglycan replacement therapy [Nourkrin®] to prevent postpartum hair loss will ultimately help long-term preservation of hair in women'

2016 Clinical Paper on postpartum hair loss

Selected published clinical studies

'It is beneficial using Nourkrin® as a continuous, baseline treatment...'

2012 Clinical Study on 100 females using Nourkrin®

Selected published clinical studies

'… Nourkrin® is recommended both as a prophylactic and a therapy, and especially in connection to stress-related hair loss …'

2016 Clinical Paper on stress-induced hair loss

Selected published clinical studies

'Nourkrin® with Marilex® has been shown to be an effective treatment for anagen induction and prolongation'


Selected published clinical studies

'It is beneficial using Nourkrin® as a continuous, baseline treatment in all types of hair loss'

2014 Clinical Paper on treating hair thinning in women


Subscribe to our newsletter to stay up to date on the newest research within the field of hair growth disorders and female hair loss, information about upcoming events and competitions with Nourkrin®.